We went to the cinema last week. Hardly something to write about. But this was different. It was […]

How did UCB close its $1.9 billion deal to buy Zogenix and its key epilepsy drug? SEC filing […]

Shkreli and Vyera settle for $28M in yet another Daraprim antitrust suit fkansteiner Tue, 02/01/2022 – 14:39

Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement esagonowsky Tue, 02/01/2022 […]

A research team based in Kumamoto University (Japan) has created complex 3D kidney tissue in the lab solely […]

Artificial intelligence (AI)-based scheduling significantly improves physician engagement and reduces burnout by creating fair and flexible schedules that […]

The UK government is taking a fresh look at gambling. A white paper, expected in spring 2022, will […]

The image of Queen Elizabeth II sitting alone in a black facemask at the funeral of her husband […]

As hospitals in the US and elsewhere fill again with patients with covid-19, discussions about how to fairly […]

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity